Documentos clave

Ver Toda la documentación

Saltar a

1081002

USP

Butalbital

Name: Butalbital
Brand: USP

United States Pharmacopeia (USP) Reference Standard

Sinónimos:

5-Allyl-5-isobutylbarbituric acid

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Talla/SKU	Disponibilidad	Precio

Acerca de este artículo

Fórmula empírica (notación de Hill):

C₁₁H₁₆N₂O₃

Número CAS:

77-26-9

Peso molecular:

224.26

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329749167

MDL number:

MFCD00056089

Beilstein/REAXYS Number:

202119

eCl@ss:

25140904

En este momento no podemos mostrarle ni los precios ni la disponibilidad

Servicio técnico

¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.

Permítanos ayudarle

Propiedades

grade

pharmaceutical primary standard

agency

USP

API family

butalbital

manufacturer/tradename

USP

drug control

USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IIC (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet, kontrollierte Droge in Deutschland

application(s)

pharmaceutical
pharmaceutical (small molecule)

format

neat

SMILES string

CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O

InChI

1S/C11H16N2O3/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16)

InChI key

UZVHFVZFNXBMQJ-UHFFFAOYSA-N

Gene Information

human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879)

Descripción

General description

Find answers to frequently asked questions on USP products in USP FAQs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Butalbital USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

Butalbital, Aspirin, and Caffeine Capsules
Butalbital, Aspirin, and Caffeine Tablets
Butalbital, Acetaminophen, and Caffeine Tablets
Butalbital, Acetaminophen, and Caffeine Capsules
Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Legal Information

German
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.

English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo	PHR8868	B006	A0325100
USP 1081002 Butalbital	Supelco PHR8868 Butalbital	Supelco B006 Butalbital solution	A0325100 Albendazole
description United States Pharmacopeia (USP) Reference Standard	description certified reference material, pharmaceutical secondary standard	description 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®	description European Pharmacopoeia (EP) Reference Standard
grade pharmaceutical primary standard	grade certified reference material, pharmaceutical secondary standard	grade certified reference material	grade pharmaceutical primary standard
manufacturer/tradename USP	manufacturer/tradename -	manufacturer/tradename Cerilliant^®	manufacturer/tradename EDQM
application(s) pharmaceutical pharmaceutical (small molecule)	application(s) pharmaceutical	application(s) forensics and toxicology	application(s) pharmaceutical pharmaceutical (small molecule)
format neat	format -	format single component solution	format neat
API family butalbital	API family -	API family -	API family -
drug control USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IIC (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet, kontrollierte Droge in Deutschland	drug control Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet, kontrollierte Droge in Deutschland	drug control Narcotic Licence Schedule B (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIC (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet, kontrollierte Droge in Deutschland	drug control -

Still not finding the right product?

Explore all of our products under Butalbital

Pictogramas

GHS07

Palabra de advertencia

Warning

Códigos de peligro

H302,H317

Indicaciones de precaución

P280 - P301 + P312 + P330

Hazard Classifications

Acute Tox. 4 Oral - Skin Sens. 1

Clase de almacenamiento

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Punto de inflamación (°F)

Not applicable

Punto de inflamación (°C)